MAPT and Alzheimer disease: However, we observed lower levels of intracellular Aβ accumulation during earlier stages of AD and determined how blocking α4 integrins affects cognitive functions using a more complex model, in which mice develop both amyloid and tau pathologies, thus more closely representing AD neuropathology in humans.